Search research articles
Contact Us
Filters
Showing results (11-20 of 119) with videos related to
Page
of 12
Sort By:
Journal of Medicinal Chemistry
|
December 13, 2002
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis)
Ilza K Pajeva, Michael Wiese
Medicinal Research Reviews
|
May 30, 2018
Small-molecule inhibitors of multidrug resistance-associated protein 1 and related processes: A historic approach and recent advances
Sven Marcel Stefan, Michael Wiese
The AAPS Journal
|
June 9, 2009
Structure-activity relationships of tariquidar analogs as multidrug resistance modulators
Ilza K Pajeva, Michael Wiese
Expert Opinion on Therapeutic Patents
|
April 29, 2014
HAGE, the helicase antigen as a biomarker for breast cancer prognosis (WO2013144616)
Michael Wiese, Ilza K Pajeva
Journal of Medicinal Chemistry
|
April 10, 2015
HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)
Sebastian C Köhler, Michael Wiese
Medicinal Research Reviews
|
April 4, 2019
The A-B-C of small-molecule ABC transport protein modulators: From inhibition to activation-a case study of multidrug resistance-associated protein 1 (ABCC1)
Michael Wiese, Sven Marcel Stefan
Journal of Medicinal Chemistry
|
May 6, 2016
Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)
Michael K Krapf, Michael Wiese
Arthritis Care & Research
|
January 13, 2025
Reply
Dorsa Maher, Emily Reeve, Michael Wiese
Pflege Zeitschrift
|
April 2, 2005
[Clinical treatment pathways--1: High quality at low cost--an incompatible goal conflict?]
Tina Küttner, Michael Wiese, Norbert Roeder
Pflege Zeitschrift
|
May 13, 2005
[Clinical treatment pathways--2: The path is the goal--and an optimized organizational methodology]
Tina Küttner, Michael Wiese, Norbert Roeder
Page
of 12
Search research articles
Search
Showing results (11-20 of 119) with videos related to
Sort By:
Page
of 12
Journal of Medicinal Chemistry
|
December 13, 2002
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis)
Ilza K Pajeva, Michael Wiese
Medicinal Research Reviews
|
May 30, 2018
Small-molecule inhibitors of multidrug resistance-associated protein 1 and related processes: A historic approach and recent advances
Sven Marcel Stefan, Michael Wiese
The AAPS Journal
|
June 9, 2009
Structure-activity relationships of tariquidar analogs as multidrug resistance modulators
Ilza K Pajeva, Michael Wiese
Expert Opinion on Therapeutic Patents
|
April 29, 2014
HAGE, the helicase antigen as a biomarker for breast cancer prognosis (WO2013144616)
Michael Wiese, Ilza K Pajeva
Journal of Medicinal Chemistry
|
April 10, 2015
HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2)
Sebastian C Köhler, Michael Wiese
Medicinal Research Reviews
|
April 4, 2019
The A-B-C of small-molecule ABC transport protein modulators: From inhibition to activation-a case study of multidrug resistance-associated protein 1 (ABCC1)
Michael Wiese, Sven Marcel Stefan
Journal of Medicinal Chemistry
|
May 6, 2016
Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)
Michael K Krapf, Michael Wiese
Arthritis Care & Research
|
January 13, 2025
Reply
Dorsa Maher, Emily Reeve, Michael Wiese
Pflege Zeitschrift
|
April 2, 2005
[Clinical treatment pathways--1: High quality at low cost--an incompatible goal conflict?]
Tina Küttner, Michael Wiese, Norbert Roeder
Pflege Zeitschrift
|
May 13, 2005
[Clinical treatment pathways--2: The path is the goal--and an optimized organizational methodology]
Tina Küttner, Michael Wiese, Norbert Roeder
Page
of 12